Two doses of Covid vaccines induce lower antibody levels against Omicron: Oxford study

Two doses of Pfizer and AstraZeneca Covid-19 vaccines generate lower levels of antibodies against the Omicron variant of coronavirus, according to a study which suggests that those previously infected or vaccinated may be at an increased risk of infection. Researchers from the University of Oxford in the UK analysed the impact of the Omicron variant of concern on one of the

Related Keywords

United Kingdom ,Astrazeneca Covid ,Gavin Screaton ,Teresa Lambe ,Matthew Snape ,Pfizer ,University Of Oxford ,United Kingdom Health Security Agency ,Head Of The Oxford Medical Sciences Division ,Professor Gavin Screaton ,Medical Sciences Division ,Coronavirus ,Coronavirus Vaccine ,Covid 19 ,Aqs ,Micron ,